|01-14-2019 04:48 PM CET - Health & Medicine||
Biopharmaceuticals Market: North America Stand With Highest Revenue Contributor in Global Industry: Opportunity Analysis And Forecast, 2018-2025
Press release from: Allied Market Research
The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period. Biopharmaceuticals are substances that are produced using living organisms, such as microorganisms and animal cells, and have a high-therapeutic value. These large and complex molecular drugs are also known as biologics and biotech drugs.
Download Report Sample @ www.alliedmarketresearch.com/request-sample/3971
Biopharmaceuticals, also known as biologics, are drugs that are manufactured in living systems, such as microorganisms and animal cells. An array of different biopharmaceuticals is also produced using recombinant DNA technology. The biopharmaceuticals sector is the fastest-growing segment of the pharmaceutical industry.
The global biopharmaceuticals market is anticipated to grow considerably in the near future, owing to various factors, such as strategic collaborations among biopharmaceuticals companies, increase in obesity and sedentary lifestyle among the population, rise in elderly population, and upsurge in prevalence of chronic diseases, such as cancer, globally. However, high costs associated with biopharmaceuticals drug development and a stringent regulatory scenario are key factors expected to impede the market growth. On the contrary, emerging markets, such as India and China, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.
By type, the monoclonal antibody segment accounted for nearly two-fifths share of the global biopharmaceuticals market in 2017. In terms of application, the oncology segment accounted for one-third share in 2017, and is projected to exhibit a prominent growth rate, owing to surge in cancer prevalence globally. By region, North America generated the highest revenue in the global biopharmaceuticals market in 2017.
North America held the highest market share in 2017, owing to high prevalence rate of cancer and other chronic diseases, adoption of biologics, and increase in awareness about biopharmaceuticals. The Asia-Pacific region is expected to grow at the highest CAGR of 17.2% during the forecast period, owing to rapid industrialization in the area, increase in disposable income, and upsurge in government initiatives to modernize the healthcare infrastructure.
The report provides an extensive competitive analysis and profiles of the key market players, such as
• Abbott Laboratories,
• Amgen, Inc.,
• Biogen, Inc.,
• Eli Lilly and Company,
• F. Hoffmann-La Roche, Ltd.,
• Johnson & Johnson,
• Merck & Co., Inc.,
• Novo Nordisk A/S,
• Pfizer, Inc., and
The other players in the value chain (not included in the report) include Bristol Myers Squibb Company, Bayer AG, and Shire plc.
Access Full Summery @ www.alliedmarketresearch.com/biopharmaceutical-market
The global biopharmaceuticals market is driven by various factors, such as increase in elderly population, surge in prevalence of chronic diseases such as cancer and diabetes, and increase in adoption of biopharmaceuticals globally. Furthermore, rise in strategic collaborations among biopharmaceuticals companies is also anticipated to supplement the growth of the biopharmaceuticals industry.
Key Findings of the Biopharmaceuticals Market:
• The monoclonal antibody segment is anticipated to dominate the global biopharmaceuticals market from 2018 to 2025.
• The metabolic disease application is anticipated to grow with the highest CAGR throughout the forecast period.
• North America accounted for a share of more than two-fifths of the global biopharmaceuticals market in 2017.
• The Asia-Pacific region is anticipated to grow at the highest rate in the global biopharmaceuticals market during the forecast period, followed by LAMEA.
Table Of Content
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis, 2017
3.4. Clinical trials
3.5. Patent analysis, 2014-2018
3.5.1. Patent analysis, by year (2014-2018)
3.5.2. Patent analysis, by country
3.6. Market dynamics
184.108.40.206. Increase in prevalence of chronic diseases
220.127.116.11. Rise in geriatric population and improvement in healthcare infrastructure
18.104.22.168. Increase in strategic acquisitions and collaborations
22.214.171.124. High cost of drug development and threat of failure
126.96.36.199. Stringent regulatory scenario
188.8.131.52. Increase in purchasing power of emerging economics
Biopharmaceuticals Market: www.medgadget.com/2018/12/biopharmaceuticals-market-size-...
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
News-ID: 1496072 • Views: 153More releases